Our Mission

Adverum is a clinical-stage gene therapy company targeting unmet medical need in ocular and rare diseases. We develop gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Our core capabilities include clinical development, novel vector discovery, and in-house manufacturing expertise, specifically in scalable process development, assay development, and current Good Manufacturing Practices (cGMP) quality control. Our team has extensive clinical development experience and is laser-focused on advancing novel gene therapies for patients.

Core Values

At Adverum, our values underscore our business and shape how we think of the patients we hope to help, how we apply science to medicine, and how we work and grow as a company.

LEAD WITH INTEGRITY  We take individual and collective responsibility to advance evidence-based science as we embark on a bold mission.
STRIVE TOGETHER  We tackle complex issues through diverse perspectives, shared decision-making, and collaboration.
PIONEER WITH PATIENTS  We use our science, technology, and expertise to innovate and optimize breakthrough products that give sight to patients across the globe.


At Adverum, our values define how we conduct business, shape patient care, apply science to medicine, and work and grow as a company. We strive to put our corporate values into action every day – by reducing the environmental impact of our research and operations, providing safe, engaging and impactful work for our employees, and always leading with integrity.

To learn more, click here.

Our Team

Print All
Laurent Fischer, M.D. President and Chief Executive Officer
Richard Beckman, M.D. Chief Medical Officer
Rupert D’Souza, Ph.D. Chief Financial Officer
Brigit Riley, Ph.D. Chief Scientific Officer
Star Seyedkazemi, PharmD Chief Development Officer
Kishor Peter Soparkar, J.D. Chief Operating Officer
Jim Wang, Ph.D. Chief Regulatory Officer
Dena House Senior Vice President, Human Resources, Organizational Development & Learning
Heikki Jouttijärvi Senior Vice President, Head of Technical Operations
Thomas Kochy Senior Vice President, Head of Global Product Strategy and Commercial
Michael Steel Senior Vice President, Quality
Bill Tan, PharmD Senior Vice President, Head of Global Clinical Operations
Anand Reddi Vice President, Head of Corporate Strategy and External Affairs & Engagement
Patrick Machado, J.D. Board Chair
Laurent Fischer, M.D. Director
Soo J. Hong, M.B.A. Director
Mark Lupher, Ph.D. Director
Rabia Gurses Ozden, M.D. Director
James Scopa, J.D., M.B.A. Director
Dawn Svoronos Director
Reed V. Tuckson, M.D. Director
Scott M. Whitcup, M.D. Director
David S. Boyer, M.D. Scientific Advisory Board Member
Jeffrey Heier, M.D. Scientific Advisory Board Member
Arshad M. Khanani, M.D., M.A. Scientific Advisory Board Member
Szilárd Kiss, M.D. Scientific Advisory Board Member
Charles C. Wykoff, M.D., Ph.D. Scientific Advisory Board Member

Contact Us

Adverum Biotechnologies, Inc., 100 Cardinal Way, Redwood City, CA 94063
Tel: 650-656-9323 General Inquiry: info@adverum.com

  • *Indicates required field